CRSP vs DHI · rev $11.6M vs P/E 9.6, rev $34.25B
Crispr Therapeutics AG (CRSP) versus DR Horton Inc (DHI) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
DR Horton Inc (DHI) is a residential construction company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
CRSP currently screens at market cap $5.42B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Not investment advice. Open the CRSP and DHI stock pages for the full models.
Not investment advice.